Contents:

Antibiotics for pulmonary infections: an overview; Antibiotic resistance in pulmonary infections: mechanisms and epidemiology; Antibiotics in critical care: dosing, therapeutic drug monitoring and continuous infusions; Inhaled antibiotics in chronic airway infections; Inhaled antibiotics in critical care; Identifying patients with pneumonia due to MDR organisms coming from the community; Antibiotic stewardship in the community; Antibiotic stewardship in the hospital setting; Antibiotics in acute exacerbation of asthma and COPD; Antifungals in pulmonary infections: to whom, when and how?; Long-term oral antibiotic treatment: why, what, when and to whom?; Macrolide therapy for patients with pneumonia: a triple-edged sword; Treatment options for MDR-and XDR-TB; Perspectives on antibiotic treatment of NTM pulmonary disease; Antibiotics for pleural infections; Antibiotics in interstitial lung diseases; Insights into antibiotic use in children with CAP; New antibiotic development for pulmonary infections: New Drugs for Bad Bugs and beyond; Combination antibiotic therapy and synergy in HAP and VAP